The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Boral Anthony L. since 2017.
The trader's CIK number is 1638468.
At the time of the last reporting, Boral Anthony L. was the Chief Medical Officer of Blueprint Medicines Corp. (stock ticker symbol BPMC).
Also see all insider trading activities at Blueprint Medicines Corp.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | BPMC | 0 | $0 | 40,536 | $3,621,818 | 49,183 | $613,939 |
2019 | BPMC | 0 | $0 | 30,000 | $2,500,659 | 30,000 | $264,000 |
2017 | BPMC | 0 | $0 | 20,000 | $1,101,735 | 20,000 | $176,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-12-14 | BPMC | Option Ex | 10,000 | 15.01 | 150,100 |
2020-12-14 | BPMC | Sale | 10,000 | 117.80 | 1,177,970 |
2020-10-23 | BPMC | Option Ex | 9,183 | 11.90 | 109,323 |
2020-09-22 | BPMC | Option Ex | 6,864 | 15.01 | 103,028 |
2020-09-22 | BPMC | Sale | 6,864 | 82.33 | 565,113 |
2020-09-17 | BPMC | Sale | 23,136 | 80.00 | 1,850,880 |
2020-09-17 | BPMC | Option Ex | 23,136 | 10.87 | 251,488 |
2020-03-09 | BPMC | Sale | 536 | 51.97 | 27,855 |
2019-12-17 | BPMC | Option Ex | 10,000 | 8.80 | 88,000 |
2019-12-17 | BPMC | Sale | 10,000 | 76.49 | 764,900 |
2019-08-20 | BPMC | Sale | 1,300 | 80.44 | 104,572 |
2019-08-21 | BPMC | Sale | 8,700 | 80.01 | 696,087 |
2019-08-20 | BPMC | Option Ex | 1,300 | 8.80 | 11,440 |
2019-08-21 | BPMC | Option Ex | 8,700 | 8.80 | 76,560 |
2019-07-08 | BPMC | Option Ex | 10,000 | 8.80 | 88,000 |
2019-07-08 | BPMC | Sale | 10,000 | 93.51 | 935,100 |
2017-11-06 | BPMC | Option Ex | 5,000 | 8.80 | 44,000 |
2017-11-06 | BPMC | Sale | 5,000 | 71.69 | 358,440 |
2017-08-09 | BPMC | Option Ex | 5,000 | 8.80 | 44,000 |
2017-08-09 | BPMC | Sale | 5,000 | 48.43 | 242,165 |
2017-06-28 | BPMC | Option Ex | 10,000 | 8.80 | 88,000 |
2017-06-28 | BPMC | Sale | 10,000 | 50.11 | 501,130 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boral Anthony L. (Chief Medical Officer of Blueprint Medicines Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.